[Eating disorders].
Hebebrand
Johannes
J
Herpertz-Dahlmann
Beate
B
D000856:Anorexia Nervosa / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000503:physiopathology; D052018:Bulimia Nervosa / Q000175:diagnosis / Q000235:genetics / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D004644:Emotions / Q000502:physiology; D001068:Feeding and Eating Disorders / Q000175:diagnosis* / Q000235:genetics / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D056726:Genetic Association Studies; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D011599:Psychopathology; D011613:Psychotherapy / Q000379:methods; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use
D014150:Antipsychotic Agents; D017367:Selective Serotonin Reuptake Inhibitors
Essstörungen.